Skip to main content
Equibles

IMMU · Mendus AB (publ)

Use IMMU with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMMU.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
6.2000 SEK -0.1500 (-2.36%) At close · Oct 2
Rebalance outlook locked
Market Cap
420.90M SEK
Shares
63.48M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close6.2000 SEK Open6.3400 SEK Day6.1500–6.3400 SEK 52W close3.9550–7.4700 SEK Avg vol 30d22K Last earningsAug 20, 2026 DataJun 2024–Oct 2026

Raw chart and full-history price indicators begin at the captured split on Jun 3, 2024; bars on opposite sides are not compared.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 3.9550 SEK Now 6.2000 SEK · 64% Range high 7.4700 SEK
vs 200-day avg +9% vs 50-day avg -9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on Jun 3, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XSTO:IMMU -4.8% -15.8% +13.8% -2.2% +10.7%

Exchange listing

Market
XSTO
Ticker
IMMU
ISIN
SE0022239950
Security
—
Trading currency
SEK

Company

Website
https://www.mendus.com/
Investor relations
https://mendus.com/investors/

Other listings of this company

No other verified listings are available.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Conference · September 2026 2026-09-02 Audio Transcript
    BioTech TV Interview with CEO Erik Manting at Pareto Securities Healthcare Conference
  • Earnings call · Q2 2026 2026-08-20 Audio Transcript
    Q2 2026 financial report and business update
  • Earnings call · Q1 2026 2026-05-08 Audio Transcript
    Q1 2026 financial report and business update
  • Earnings call · Q4 2025 2026-02-11 Audio Transcript
    Q4 2025 financial report and business update